Skip to search formSkip to main contentSkip to account menu

ivacaftor 125 MG / lumacaftor 200 MG Oral Tablet [ORKAMBI]

Known as: ORKAMBI (lumacaftor 200 MG / ivacaftor 125 MG) Oral Tablet, ORKAMBI 200 MG / 125 MG Oral Tablet, lumacaftor 200 mg / ivacaftor 125 mg ORAL TABLET, FILM COATED [ORKAMBI] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
F508del‐cystic fibrosis transmembrane conductance regulator (CFTR) is the major mutant responsible for cystic fibrosis (CF… 
2017
2017
Fachkommunikation (Sales Folder, DDI Facher) Patientenkommunikation (Therapiestart, Ernahrungshinweise) Patientenkommunikation… 
2017
2017
Objectives: Recently, the combination of CFTR potentiator ivacaftor and CFTR corrector lumacaftor (Orkambi®) has been shown to… 
2016
2016
F Die Präsentationen beinhalteten neue Real World Daten aus einer noch andauernden fünfjährigen Beobachtungstudie, die die…